Lazard Frères Gestion’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$137M Sell
1,580,855
-125,081
-7% -$12M 2.7% 10
2025
Q4
$164M Buy
1,705,936
+175,159
+11% +$17M 2.95% 10
2025
Q3
$146M Buy
1,530,777
+91,505
+6% +$8.41M 2.78% 10
2025
Q2
$125M Buy
1,439,272
+58,142
+4% +$4.93M 2.62% 10
2025
Q1
$124M Sell
1,381,130
-149,803
-10% -$13.4M 3.02% 11
2024
Q4
$122M Buy
1,530,933
+371,742
+32% +$32.2M 2.45% 14
2024
Q3
$104M Buy
1,159,191
+220,556
+23% +$18.6M 2.21% 16
2024
Q2
$71.5M Buy
938,635
+107,475
+13% +$8.81M 1.65% 21
2024
Q1
$69.5M Buy
831,160
+65,431
+9% +$5.58M 1.72% 20
2023
Q4
$60.1M Buy
765,729
+59,266
+8% +$4.52M 1.73% 19
2023
Q3
$53.6M Buy
706,463
+5,974
+0.9% +$500K 1.7% 21
2023
Q2
$58.8M Buy
700,489
+22,187
+3% +$1.91M 1.8% 17
2023
Q1
$48.7M Buy
678,302
+57,935
+9% +$4.72M 1.8% 18
2022
Q4
$46.5M Buy
620,367
+40,330
+7% +$3.27M 1.68% 21
2022
Q3
$47.5M Buy
580,037
+7,066
+1% +$635K 1.8% 18
2022
Q2
$50M Buy
572,971
+2,643
+0.5% +$268K 1.8% 17
2022
Q1
$59.2M Buy
570,328
+38,211
+7% +$4.04M 1.78% 18
2021
Q4
$50.9M Buy
532,117
+10,182
+2% +$1.18M 1.37% 25
2021
Q3
$65.4M Buy
521,935
+460
+0.1% +$59.5K 1.84% 21
2021
Q2
$54.6M Sell
521,475
-16,635
-3% -$2.09M 1.76% 23
2021
Q1
$54.1M Buy
538,110
+5,510
+1% +$646K 1.88% 23
2020
Q4
$62.6M Buy
+532,600
New +$58.6M 2% 25

Other funds holding MDT

Lazard Frères Gestion's MDT Position: Q1 2026 in Review

Lazard Frères Gestion reduced its Medtronic (MDT) stake by 7.3% in Q1 2026, selling an estimated $12M and leaving 1,580,855 shares worth $137M. The position accounts for 2.7% of the portfolio, ranked #10.

Lazard Frères Gestion first reported a position in MDT in Q4 2020 and has held it in 22 quarters since. The position peaked at $164M in Q4 2025. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Lazard Frères Gestion held 1,580,855 shares of Medtronic worth $137M as of Q1 2026.
  • Lazard Frères Gestion sold 125,081 Medtronic shares in Q1 2026, an estimated $12M.
  • Medtronic made up 2.7% of Lazard Frères Gestion's portfolio in Q1 2026, its #10 holding.
  • Lazard Frères Gestion first reported a position in Medtronic in Q4 2020 and has held it in 22 quarters since.
  • Lazard Frères Gestion's Medtronic position peaked at $164M in Q4 2025.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Lazard Frères Gestion's 13F filing for Q1 2026, filed 7 May 2026.